Venous Compression in Fontan

NCT ID: NCT07220226

Last Updated: 2026-01-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

NOT_YET_RECRUITING

Clinical Phase

NA

Total Enrollment

20 participants

Study Classification

INTERVENTIONAL

Study Start Date

2026-01-10

Study Completion Date

2027-11-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The aim of this study is to investigate whether venous compression garments increase exercise stroke volume in patients with Fontan circulation. To address this aim, we will test the following hypotheses:

1. Acute and chronic external venous compression will increase exercise stroke volume in patients with Fontan circulation.
2. Patients with significant venous varicosities will have a greater response to venous compression.

Participants will:

* Undergo submaximal exercise testing in MRI to measure venous return and exercise stroke volume with and without the wearing of compression garments
* Undergo submaximal exercise testing on a seated upright exercise ergometer with concurrent measurement of stroke volume with and without the wearing of compression garments
* A subset of participants will repeat both testing visits after wearing compression garments for 2-weeks during waking hours.

Participants will:

* Undergo submaximal exercise testing in MRI to measure venous return and exercise stroke volume with and without the wearing of compression garments
* Undergo submaximal exercise testing on a seated upright exercise ergometer with concurrent measurement of stroke volume with and without the wearing of compression garments
* A subset of participants will repeat both testing visits after wearing compression garments for 2-weeks during waking hours.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Study Day 1 - Consent, Screening and Garment Measurements:

Following assessment of participant eligibility, all participants will undergo leg venous ultrasound assessment and abdominal-foot measurements for the custom making of compression garments.

Study Day 2 - MRI:

Study participants will undergo comprehensive cardiovascular MRI using a 3T MRI scanner with and without compression garments and exercise.

Study Day 3 - Cardiovascular \& Exercise Testing Day:

All participants will undergo comprehensive cardiovascular structure and function assessments at rest and during exercise with and without the wearing of compression garments. Baseline testing will include dual x-ray absorptiometry (DEXA), pulmonary function testing, comprensive vascular assessments and echocardiography. During exercise at two submaximal workloads, the study team will measure blood pressure, oxygen uptake and cardiac output.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Single-ventricle Fontan Circulation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

SEQUENTIAL

Primary Study Purpose

OTHER

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Fontan circulation Arm

Fontan circulation participants will undergo Rest +Submax exercise with and without wearing venous compression garments.

A subset of patients with Fontan circulation will undergo repeat testing 2-weeks later.

Group Type EXPERIMENTAL

Lower extremity compression garments

Intervention Type DEVICE

Acute and 2-week effects of compression garments

Without compression garments

Intervention Type OTHER

Acute effects without compression garments

Healthy controls

Healthy group participants will undergo Rest +Submax exercise with and without wearing venous compression garments.

Group Type EXPERIMENTAL

Lower extremity compression garments

Intervention Type DEVICE

Acute and 2-week effects of compression garments

Without compression garments

Intervention Type OTHER

Acute effects without compression garments

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Lower extremity compression garments

Acute and 2-week effects of compression garments

Intervention Type DEVICE

Without compression garments

Acute effects without compression garments

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

• Patients at UTSW aged 18-45 years old with a Fontan circulation.

Exclusion Criteria

* NYHA Class 4
* Severe AV valve regurgitation
* Severe ventricular dysfunction
* Large ascites
* Significant varicosities
* Atrio-pulmonary (AP) Fontan
* Known Fontan thrombus
* Poorly controlled arrythmia
* Unplanned cardiac admission in the last 6 months
* Cyanosis (resting O2 saturation \<85%)
* Pregnant
* Common femoral vein obstruction \>50% to be performed following completion of informed consent.

Healthy Controls:

Healthy control participants will be recruited on the basis of having no known chronic diseases and not currently taking any cardiovascular medications.
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

University of Texas Southwestern Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Keri Shafer

Associate Professor of Medicine

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Keri Shafer, MD

Role: PRINCIPAL_INVESTIGATOR

University of Texas Southwestern Medical Center

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Keri Shafer, MD

Role: CONTACT

2146451165

Denis J Wakeham, PhD

Role: CONTACT

2146451165

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

STU20250885

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Compression Device Safety Study
NCT00732823 COMPLETED PHASE2